Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enterobacterales carrying chromosomal AmpC β-lactamases in Europe (EuESCPM): Epidemiology and antimicrobial resistance burden from a cohort of 27 hospitals, 2020-2022.
Boattini M, Bianco G, Llorente LI, Acero LA, Nunes D, Seruca M, Mendes VS, Almeida A, Bastos P, Rodríguez-Villodres Á, Gascón AG, Halperin AV, Cantón R, Escartín MNL, González-López JJ, Floch P, Massip C, Chainier D, Barraud O, Dortet L, Cuzon G, Zancanaro C, Mizrahi A, Schade R, Rasmussen AN, Schønning K, Hamprecht A, Schaffarczyk L, Glöckner S, Rödel J, Kristóf K, Balonyi Á, Mancini S, Quiblier C, Fasciana T, Giammanco A, Paglietti B, Rubino S, Budimir A, Bedenić B, Rubic Z, Marinović J, Gartzonika K, Christaki E, Mavromanolaki VE, Maraki S, Yalçın TY, Azap ÖK, Licker M, Musuroi C, Talapan D, Vrancianu CO, Comini S, Zalas-Więcek P, Michalska A, Cavallo R, Melo Cristino J, Costa C. Boattini M, et al. Among authors: comini s. Int J Antimicrob Agents. 2024 May;63(5):107115. doi: 10.1016/j.ijantimicag.2024.107115. Epub 2024 Feb 16. Int J Antimicrob Agents. 2024. PMID: 38367844 Free article.
Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era.
Bianco G, Boattini M, Comini S, Casale R, Iannaccone M, Cavallo R, Costa C. Bianco G, et al. Among authors: comini s. Eur J Clin Microbiol Infect Dis. 2022 Apr;41(4):573-580. doi: 10.1007/s10096-022-04408-5. Epub 2022 Jan 21. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35061145 Free PMC article.
Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019-2021): emergence of complex resistance phenotypes.
Bianco G, Boattini M, Comini S, Iannaccone M, Casale R, Allizond V, Barbui AM, Banche G, Cavallo R, Costa C. Bianco G, et al. Among authors: comini s. J Chemother. 2022 Sep;34(5):302-310. doi: 10.1080/1120009X.2022.2031471. Epub 2022 Jan 31. J Chemother. 2022. PMID: 35098907
Outbreak of ceftazidime-avibactam resistant Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in a COVID-19 intensive care unit, Italy: urgent need for updated diagnostic protocols of surveillance cultures.
Bianco G, Boattini M, Bondi A, Comini S, Zaccaria T, Cavallo R, Costa C. Bianco G, et al. Among authors: comini s. J Hosp Infect. 2022 Apr;122:217-219. doi: 10.1016/j.jhin.2022.02.001. Epub 2022 Feb 6. J Hosp Infect. 2022. PMID: 35139426 Free PMC article. No abstract available.
48 results